European Market Report for Insulin Syringes 2016 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "European Market Report for Insulin Syringes 2016 - MedCore" report to their offering.

The insulin syringe market is a fast declining segment. Although the product was once a popular method of injecting insulin, patients have transitioned towards new technologies such as insulin pens and pumps, thereby cannibalizing the insulin syringe segment. Safety insulin syringes are now mainly used in professional healthcare settings, such as hospitals, whereas conventional syringes are no longer used as frequently. Syringe use is still relatively high in Italy due to historical trends, but it is expected that patients will continue to switch to insulin pens and pumps for convenience.

Insulin is a protein and when administered orally, it degrades in the stomach and the intestines. When administered subcutaneously, it is better absorbed and has more of an effect on blood sugar levels. Many alternative technologies have entered the insulin delivery device market, such as insulin pumps and insulin pens, resulting in a fast decline in insulin syringe use across Europe.

Insulin syringes are moving from being hypodermic to those with finer points. Syringes are used with 10 mL insulin vials and come in 0.3 mL, 0.5 mL and 1 mL calibrations. In addition, thinner and shorter syringes are becoming more popular in the market, as they cause less discomfort when giving an injection. Needle thickness is indicated by gauge number; the higher the gauge number, the thinner the needle.

Key Topics Covered:

1. Research Methodology

3. Disease Overview

2.1 Introduction

2.1.1 Types Of Diabetes

2.1.2 Diabetes Complications

2.1.3 Risk Factors Associated With Type 1 And Type 2 Diabetes

2.1.4 Signs And Symptoms

2.1.5 Diabetes Monitoring

2.1.6 Treatment

2.1.7 Drug Delivery Systems

3. Country Profiles

3.1 Introduction

3.1.1.1 Population

3.1.1.2 Gdp Per Capita

3.1.1.3 Units

4. Insulin Syringe Market

4.1 Introduction

4.2 Market Analysis And Forecast

4.3 Drivers And Limiters

4.4 Competitive Market Share Analysis

Companies Mentioned

  • Novo Nordisk
  • Sanofi
  • Roche
  • Johnson & Johnson
  • Eli Lilly
  • Abbott
  • Ascensia
  • Becton Dickinson
  • Medtronic
  • Menarini
  • DexCom
  • Ypsomed
  • Insulet
  • Artsana
  • B. Braun
  • Terumo

For more information about this report visit http://www.researchandmarkets.com/research/qfxdfq/european_market

Related Topics: Infusions and Injectables , Needles and Syringes

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716